COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1495: Articles 14941-14950  | Next

SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization
Jackson, L., Rodel, H., Hwa, S.-H., Cele, S., Ganga, Y., Tegally, H., Bernstein, M., Giandhari, J., COMMIT-KZN Team, , Gosnell, B. I., Khan, K., Hanekom, W., Karim, F., de Oliveira, T., Moosa, M.-Y. S., Sigal, A.
10.1101/2021.06.01.446516 — Posted: 2021-06-01
Virucidal activity of a proprietary blend of plant-based oils (Viruxal) against SARS-CoV-2 and influenza viruses - an in vitro study
Kristjansson, J. M., Rolfsson, O.
10.1101/2021.05.31.446420 — Posted: 2021-06-01
Synergistic inhibition of two host factors that facilitate entry of Severe Acute Respiratory Syndrome Coronavirus 2
Kreutzberger, A. J. B., Sanyal, A., Ojha, R., Pyle, J., Vapalahti, O., Balistreri, G., Kirchhausen, T.
10.1101/2021.06.01.446623 — Posted: 2021-06-01
Structural basis for SARS-CoV-2 Nucleocapsid protein recognition by single-domain antibodies
Ye, Q., Lu, S., Corbett, K. D.
10.1101/2021.06.01.446591 — Posted: 2021-06-01
Epidemiological profile study of COVID-19 in West African countries: Nigeria, Senegal, Mauritania, Cape Verde and Mali
Ba, M. F., Diop, B., Bassoum, O., Sougou, N. M., Niang, K., Bonnet, E., Ridde, V., Faye, A.
10.1101/2021.05.31.21258118 — Posted: 2021-06-01
Effect of 2021 Assembly Election in India on Covid-19 Transmission
Manik, S., Pal, S., Mandal, M., Hazra, M.
10.1101/2021.05.30.21258040 — Posted: 2021-06-01
Signatures of mast cell activation are associated with severe COVID-19
Tan, J., Anderson, D., Rathore, A. P. S., O'Neill, A., Mantri, C. K., Saron, W. A. A., Lee, C., Chu, W. C., Kang, A., Foo, R., Kalimuddin, S., Low, J., Ho, L., Tambyah, P., Burke, T. W., Woods, C. W., Chan, K. R., Karhausen, J., St John, A. L.
10.1101/2021.05.31.21255594 — Posted: 2021-06-01 Discussion: Onsite | Offsite
Genomic epidemiology and associated clinical outcomes of a SARS-CoV-2 outbreak in a general adult hospital in Quebec
Pare, B., Rozendaal, M., Morin, S., Poujol, R., Mostefai, F., Grenier, J.-C., Kaufmann, L., Xing, H., Sanchez, M., Yechouron, A., Racette, R., Hussin, J., Wolf, G., Pavlov, I., Smith, M. A.
10.1101/2021.05.29.21257760 — Posted: 2021-06-01
COVID-19 Associated Mucormycosis: Scoping Review Protocol
Hussain, S., Baxi, H., Riad, A., Kulgarova, J., Licenik, R., Klugar, M.
10.1101/2021.05.30.21258068 — Posted: 2021-06-01
Stopping the misinformation: BNT16b2 COVID-19 vaccine has no negative effect on women's fertility
Safrai, M., Rottenstreich, A., Herzberg, S., Imbar, T., Reubinoff, B., Ben-Meir, A.
10.1101/2021.05.30.21258079 — Posted: 2021-06-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).